CABOT MEDICAL CORPORATION
COMPUTATION OF EARNINGS PER SHARE
(UNAUDITED)
(In Thousands, except per share amounts) EXHIBIT 11
----------
PRIMARY EARNINGS PER SHARE
- --------------------------
Three months ended Six months ended
April 29, April 30, April 29, April 30,
-------------------- -------------------
1995 1994 1995 1994
---- ---- ---- ----
Computation for Statement of Earnings
- -------------------------------------
Reconciliation of net earnings, per
consolidated statement of earnings
to amount used in primary earnings
per share computation:
Net earnings (loss) $( 64) $ 1,127 $ 155 $ 2,175
Add-Interest on long-term debt,
net of tax effect, on application
of assumed proceeds from exercise
of options and warrants in excess
of 20% limitation --- --- --- 77
-------- -------- ------- -------
Net earnings (loss), as adjusted $( 64) $ 1,127 $ 155 $ 2,252
-------- -------- ------- -------
Reconcilation of weighed average
number of shares outstanding to amount
used in primary earnings per share
computation:
Weighted average number of shares
outstanding 10,359 10,304 10,333 10,278
Add-Equivalent shares issuable
from assumed exercise of options
and warrants in excess of 20%
limitation --- 960 --- 1,045
------- ------ ------ ------
Weighted average number of shares
outstanding, as adjusted 10,359 11,264 10,333 11,323
------ ------ ------ ------
Primary earnings per share $( .01) $ .10 $ .02 $ .20
-------- ------- ------- -------
18
CABOT MEDICAL CORPORATION
COMPUTATION OF EARNINGS PER SHARE (CONTINUED)
(UNAUDITED)
(In Thousands, except per share amounts) EXHIBIT 11
----------
FULLY DILUTED EARNINGS PER SHARE Three months ended Six months ended
- --------------------------------
April 29, April 30, April 29, April 30,
--------------------- --------------------
1995 1994 1995 1994
---- ---- ---- ----
Computation for Statement of Earnings
- -------------------------------------
Reconciliation of net earnings, per
consolidated statement of earnings
to amount used for fully diluted
earnings per share computation:
Net earnings (loss) $( 64) $ 1,127 $ 155 $ 2,175
Add-Interest on long-term debt,
net of tax effect, on application
of assumed proceeds from exercise
of options and warrants in excess
of 20% limitation --- --- --- ---
------- ------ ------- --------
Net earnings (loss), as adjusted $( 64) $ 1,127 $ 155 $ 2,175
------- ------- ------- -------
Reconciliation of weighted average
number of shares outstanding
to amount used for fully diluted
computation:
Weighted average number of shares
outstanding 10,359 10,304 10,333 10,278
Add-Equivalent shares issuable
from assumed exercise of options
and warrants in excess of 20%
limitation --- 967 --- 1,049
------ ------ ------ ------
Weighted average number of shares
outstanding, as adjusted 10,359 11,271 10,333 11,327
------ ------ ------ ------
Fully diluted earnings per share $( .01) $ .10 $ .02 $ .19
------- ------ ------ -------
19